Herbert J. Conrad - Jan 13, 2021 Form 4 Insider Report for Matinas BioPharma Holdings, Inc. (MTNB)

Role
Director
Signature
/s/_ Keith A. Kucinski, attorney-in fact for Herbert J. Conrad
Stock symbol
MTNB
Transactions as of
Jan 13, 2021
Transactions value $
$0
Form type
4
Date filed
5/24/2021, 05:30 PM
Next filing
Jun 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MTNB Common Stock, par value $0.0001 per share Gift $0 -50K -9.18% $0.00 495K Jan 13, 2021 Direct
transaction MTNB Common Stock, par value $0.0001 per share Gift $0 +50K +40% $0.00 175K Jan 13, 2021 By Herbert J. Conrad Trust u/a/d 3/4/2005, Herbert J Conrad, Susan Wachtel, Nancy Fallick, Trustees
transaction MTNB Common Stock, par value $0.0001 per share Gift $0 -1.15M -100% $0.00* 0 May 20, 2021 By Herbert Conrad 2019 Grantor Retained Annuity Trust (GRAT)
transaction MTNB Common Stock, par value $0.0001 per share Gift $0 +1.15M +654.8% $0.00 1.32M May 20, 2021 By Herbert J. Conrad Trust u/a/d 3/4/2005, Herbert J Conrad, Susan Wachtel, Nancy Fallick, Trustees
holding MTNB Common Stock, par value $0.0001 per share 2.64M Jan 13, 2021 By Herbert Conrad 2020 Grantor Retained Annuity Trust (GRAT)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MTNB Series B Convertible Preferred Stock Gift -$100K -100 -100% $1,000.00* 0 Jan 13, 2021 Common Stock 200K $0.50 Direct F1
transaction MTNB Series B Convertible Preferred Stock Gift $100K +100 $1,000.00* 100 Jan 13, 2021 Common Stock 200K $0.50 By Herbert J. Conrad Trust u/a/d 3/4/2005, Herbert J Conrad, Susan Wachtel, Nancy Fallick, Trustees F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date.